CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-10-13 | Tullman Stephen A. Director | Conversion · Series B Preferred Stock | −31,913 | 0 | ||
| 2015-10-13 | Tullman Stephen A. Director | Conversion · Series C Preferred Stock | −17,437 | 0 | ||
| 2015-10-08 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +21,691 | $11.00 | $239K | 2,237,130 |
| 2015-10-07 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +938,041 | $10.66 | $10.0M | 938,041 |
| 2015-10-07 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +1,250,000 | $11.00 | $13.8M | 2,188,041 |
| 2015-10-07 | RA CAPITAL MANAGEMENT, LLC 10% owner | Purchase | +27,398 | $11.00 | $301K | 2,215,439 |
| 2015-10-07 | VIVO VENTURES VII, LLC 10% owner | Purchase | +13,067 | $11.00 | $144K | 296,739 |
| 2015-10-07 | VIVO VENTURES VII, LLC 10% owner | Purchase | +285 | $11.00 | $3K | 6,467 |
| 2015-10-07 | CHA ALBERT Director | Purchase | +13,352 | $11.00 | $147K | 303,206 |
| 2015-10-06 | Bierly Rick Director | Grant or award · Stock Option (right to buy) | +17,800 | 17,800 |
Page 57 of 57 · 1,130 trades